Voyager Therapeutics Inc (VYGR)
5.43
+0.07
(+1.31%)
USD |
NASDAQ |
Nov 21, 16:00
5.425
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Enterprise Value: -48.74M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -48.74M |
| November 20, 2024 | -52.57M |
| November 19, 2024 | -57.48M |
| November 18, 2024 | -51.20M |
| November 15, 2024 | -37.27M |
| November 14, 2024 | -5.589M |
| November 13, 2024 | 20.09M |
| November 12, 2024 | 27.73M |
| November 11, 2024 | 37.57M |
| November 08, 2024 | 44.12M |
| November 07, 2024 | 42.48M |
| November 06, 2024 | 52.31M |
| November 05, 2024 | 17.90M |
| November 04, 2024 | 17.90M |
| November 01, 2024 | 37.02M |
| October 31, 2024 | 27.73M |
| October 30, 2024 | 28.28M |
| October 29, 2024 | 40.84M |
| October 28, 2024 | 38.11M |
| October 25, 2024 | 22.80M |
| October 24, 2024 | 13.25M |
| October 23, 2024 | 5.345M |
| October 22, 2024 | -7.745M |
| October 21, 2024 | 72.43M |
| October 18, 2024 | 94.79M |
| Date | Value |
|---|---|
| October 17, 2024 | 91.52M |
| October 16, 2024 | 86.07M |
| October 15, 2024 | 28.25M |
| October 14, 2024 | 56.07M |
| October 11, 2024 | 46.25M |
| October 10, 2024 | 29.34M |
| October 09, 2024 | 23.34M |
| October 08, 2024 | 40.80M |
| October 07, 2024 | 24.98M |
| October 04, 2024 | 38.62M |
| October 03, 2024 | -18.65M |
| October 02, 2024 | -27.93M |
| October 01, 2024 | -26.29M |
| September 30, 2024 | -26.29M |
| September 27, 2024 | -52.00M |
| September 26, 2024 | -49.82M |
| September 25, 2024 | -56.36M |
| September 24, 2024 | -41.64M |
| September 23, 2024 | -38.37M |
| September 20, 2024 | -30.19M |
| September 19, 2024 | -26.37M |
| September 18, 2024 | -31.28M |
| September 17, 2024 | -30.73M |
| September 16, 2024 | -31.28M |
| September 13, 2024 | -30.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-57.48M
Minimum
Nov 19 2024
335.75M
Maximum
Jun 20 2023
102.24M
Average
92.28M
Median
Dec 15 2022
Enterprise Value Benchmarks
| Rhythm Pharmaceuticals Inc | 3.329B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.044M |
| Revenue (Quarterly) | 24.63M |
| Total Expenses (Quarterly) | 38.41M |
| EPS Diluted (Quarterly) | -0.16 |
| Profit Margin (Quarterly) | -36.72% |
| Earnings Yield | 11.97% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | 11.97 |